Early pipeline programs in focus

Late-stage pipeline programs in focus

ASCO 2021 Highlight

Q&A

William Pao, M.D., Ph.D.,Global Head of Roche Pharma Research and Early Development Ira Mellman, Ph.D., Vice President, Cancer Immunology, Genentech Research & Early Development

Levi Garraway, M.D., Ph.D., Chief Medical Officer and Head of Global Product Development

Tecentriq in adjuvant NSCLC: Phase 3 IMpower010 primary results Heather Wakelee, M.D., Prof. of Medicine, Stanford University Medical Center / Deputy Director Stanford Cancer Institute

Please register to access the webcast*